高樂股份(002348.SZ):大股東協議轉讓2.2%的股份予楊朝偉已完成過户
格隆匯10月20日丨高樂股份(002348.SZ)公佈,此前披露,新鴻輝實業於2021年10月8日與楊朝偉及海通證券簽訂了《股份轉讓協議》,對部分股票質押採用協議轉讓方式進行處置,新鴻輝實業通過協議轉讓方式轉讓其持有的公司2083.84萬股無限售流通股,佔公司股份總數的2.2%。
公司2021年10月20日收到公司大股東普寧市新鴻輝實業投資有限公司(“新鴻輝實業”)的通知,公司大股東新鴻輝實業協議轉讓公司部分股份給楊朝偉的事宜已在中國證券登記結算有限責任公司完成了過户登記手續。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.